Page last updated: 2024-08-17

tubocurarine and Alzheimer Disease

tubocurarine has been researched along with Alzheimer Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chun, W; Hassan, M; Kloczkowski, A; Shahzadi, S; Yasir, M1
Donati, F; Eshelby, D; Fox, GS; Ibebunjo, C; Tchervenkov, JI1
Badia, A; Baños, JE; Barril, X; Camps, P; Luque, FJ; Morral, J; Muñoz-Torrero, D; Orozco, M; Vivas, NM1

Other Studies

3 other study(ies) available for tubocurarine and Alzheimer Disease

ArticleYear
Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.
    Scientific reports, 2023, 10-21, Volume: 13, Issue:1

    Topics: Alzheimer Disease; Astemizole; Drug Repositioning; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Prognosis; Tubocurarine

2023
The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:2

    Topics: Administration, Oral; Alzheimer Disease; Anesthesia, General; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Drug Resistance; Electric Stimulation; Female; Injections, Intravenous; Muscle Contraction; Muscle, Skeletal; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Nootropic Agents; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Respiration, Artificial; Synapses; Tacrine; Time Factors; Tubocurarine

1997
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Journal of medicinal chemistry, 2000, Nov-30, Volume: 43, Issue:24

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Bridged Bicyclo Compounds; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Humans; In Vitro Techniques; Male; Mice; Models, Molecular; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Neuroprotective Agents; Quinolines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine; Tubocurarine

2000